Drug Shortage Report for APO-VALSARTAN

Last updated on 2019-03-08 History
Report ID 549
Drug Identification Number 02371537
Brand name APO-VALSARTAN
Common or Proper name VALSARTAN
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) VALSARTAN
Strength(s) 160MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL & 500 BTL & 30 BLS
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-10-01
Estimated end date Unknown
Actual end date 2018-12-27
Shortage status Resolved
Updated date 2019-03-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2019-03-08 French Compare
v12 2019-03-08 English Compare
v11 2018-12-27 French Compare
v10 2018-12-27 English Compare
v9 2018-12-06 French Compare
v8 2018-12-06 English Compare
v7 2018-12-06 English Compare
v6 2018-11-30 French Compare
v5 2018-11-30 English Compare
v4 2018-09-04 French Compare
v3 2018-09-04 English Compare
v2 2017-03-11 French Compare
v1 2017-03-11 English Compare

Showing 1 to 13 of 13